These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8241510)

  • 1. Expression and release of CD27 in human B-cell malignancies.
    van Oers MH; Pals ST; Evers LM; van der Schoot CE; Koopman G; Bonfrer JM; Hintzen RQ; von dem Borne AE; van Lier RA
    Blood; 1993 Dec; 82(11):3430-6. PubMed ID: 8241510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of serum and cerebrospinal fluid soluble CD27 in the diagnosis of leptomeningeal involvement of hematolymphoid malignancies.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(4):741-7. PubMed ID: 17901023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant expression of CD27 and soluble CD27 (sCD27) in HIV infection and in AIDS-associated lymphoma.
    Widney D; Gundapp G; Said JW; van der Meijden M; Bonavida B; Demidem A; Trevisan C; Taylor J; Detels R; Martínez-Maza O
    Clin Immunol; 1999 Nov; 93(2):114-23. PubMed ID: 10527687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of soluble CD27 and interleukins-8 and -10 in B-cell chronic lymphocytic leukemia: correlation with disease stage and prognosis.
    Kara IO; Sahin B; Gunesacar R
    Adv Ther; 2007; 24(1):29-40. PubMed ID: 17526459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human Lyb-2 homolog CD72 is a marker for progenitor B-cell leukemias.
    Schwarting R; Castello R; Moldenhauer G; Pezzutto A; von Hoegen I; Ludwig WD; Parnes JR; Dörken B
    Am J Hematol; 1992 Nov; 41(3):151-8. PubMed ID: 1384316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal association of CD40 antigen expression with discrete stages of human B-cell ontogeny and the efficacy of anti-CD40 immunotoxins against clonogenic B-lineage acute lymphoblastic leukemia as well as B-lineage non-Hodgkin's lymphoma cells.
    Uckun FM; Gajl-Peczalska K; Myers DE; Jaszcz W; Haissig S; Ledbetter JA
    Blood; 1990 Dec; 76(12):2449-56. PubMed ID: 1702326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD148 and CD27 are expressed in B cell lymphomas derived from both memory and naïve B cells.
    Dong HY; Shahsafaei A; Dorfman DM
    Leuk Lymphoma; 2002 Sep; 43(9):1855-8. PubMed ID: 12685844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies.
    van den Bent MJ; Lamers CH; van 't Veer MB; Sillevis Smitt PA; Bolhuis RL; Gratama JW
    Ann Hematol; 2002 Apr; 81(4):187-91. PubMed ID: 11976819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a human homing receptor (CD44) in lymphoid malignancies and related stages of lymphoid development.
    Horst E; Meijer CJ; Radaskiewicz T; van Dongen JJ; Pieters R; Figdor CG; Hooftman A; Pals ST
    Leukemia; 1990 May; 4(5):383-9. PubMed ID: 2201831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum soluble CD27, but not thymidine kinase, is an independent prognostic factor for outcome in indolent non-Hodgkin's lymphoma.
    Kok M; Bonfrer JM; Korse CM; de Jong D; Kersten MJ
    Tumour Biol; 2003; 24(1):53-60. PubMed ID: 12743427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD27 and its ligand, CD70, on chronic lymphocytic leukemia B cells.
    Ranheim EA; Cantwell MJ; Kipps TJ
    Blood; 1995 Jun; 85(12):3556-65. PubMed ID: 7540066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD70 reverse signaling enhances NK cell function and immunosurveillance in CD27-expressing B-cell malignancies.
    Al Sayed MF; Ruckstuhl CA; Hilmenyuk T; Claus C; Bourquin JP; Bornhauser BC; Radpour R; Riether C; Ochsenbein AF
    Blood; 2017 Jul; 130(3):297-309. PubMed ID: 28495792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum levels of soluble forms of T cell activation antigens CD27 and CD25 in systemic lupus erythematosus in relation with lymphocytes count and disease course.
    Swaak AJ; Hintzen RQ; Huysen V; van den Brink HG; Smeenk JT
    Clin Rheumatol; 1995 May; 14(3):293-300. PubMed ID: 7641505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
    Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MY4 expression on B-lymphocyte malignancies may be associated with a more adverse prognosis.
    Warzynski MJ; Otto RN; Steingart RH; White CF; Rosen MH; Hetzel PC; Flatow FA; Podgurski AE; Johnson ML
    Leuk Res; 1991; 15(5):357-65. PubMed ID: 2046387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis.
    Hintzen RQ; Paty D; Oger J
    J Neurol Neurosurg Psychiatry; 1999 Jun; 66(6):791-3. PubMed ID: 10329758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid soluble CD27 levels in children with non-Hodgkin lymphomas.
    Yalçin B; Canpinar H; Kutluk MT; Varan A; Akyüz C; Büyükpamukçu M
    Pediatr Hematol Oncol; 2004 Dec; 21(8):717-23. PubMed ID: 15739627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.